Portfolio company
Ångström AI
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops generative artificial intelligence molecular simulations for pharmaceutical and biotechnology firms to verify the efficacy and safety of new drug candidates.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Achira
This company develops atomistic simulation software combining physics and machine learning to enable drug discovery for biotechnology and pharmaceutical organisations.
Variartional
This company develops generative artificial intelligence to accelerate the discovery and optimization of novel small molecules for biopharmaceutical researchers and drug developers.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
DreamFold AI
This company develops generative artificial intelligence models for protein design to discover medicines for pharmaceutical and biotechnology researchers.
Duplicat
This company develops artificial intelligence technology to accelerate molecular discovery and enhance drug compound identification for pharmaceutical businesses.
Deep Origin
This company provides a computational drug discovery platform for biopharmaceutical researchers to simulate molecular properties and accelerate therapeutic development.
Genesis Molecular AI
The company develops an artificial intelligence platform for molecular drug discovery to assist pharmaceutical firms in designing and optimising small molecule medicines.
DreamFold
This company develops generative AI models for protein design to discover new therapeutic drugs for pharmaceutical researchers and clinicians.
